IBD and Environment: Are There Differences between East and West

Digestive Diseases

Volumn 34, Issue 1-2, 2016, Pages 84-89

  Gearry, Richard B ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Crohn's disease; Environment; Epidemiology; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

ANTIBIOTIC AGENT;

APPENDECTOMY; ASIA; AUSTRALIA AND NEW ZEALAND; BREAST FEEDING; CASE CONTROL STUDY; COHORT ANALYSIS; CONFERENCE PAPER; CROHN DISEASE; DIET; EASTERN HEMISPHERE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIDEMIC; EUROPE; FAMILY HISTORY; GASTROENTEROLOGY; GASTROINTESTINAL INFECTION; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; INCIDENCE; INFLAMMATORY BOWEL DISEASE; MICROBIOME; NORTH AMERICA; PARENT; PHENOTYPE; POPULATION MIGRATION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; ULCERATIVE COLITIS; URBANIZATION; VACCINATION; WESTERN DIET; WESTERN HEMISPHERE; ENVIRONMENT; INFLAMMATORY BOWEL DISEASES; INTERNATIONAL COOPERATION; PATHOLOGY;

ENVIRONMENT; GASTROENTEROLOGY; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERNATIONALITY; RISK FACTORS;

EID: 84962374861     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000442933     Document Type: Conference Paper

References (40)

1. Crohn B, Ginzberg L, Oppenheimer G: Regional enteritis: A clinical and pathological entity. JAMA 1932; 99: 1323-1329.
2. Kaplan GG: The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol 2015; 12: 720-727.
3. Gearry RB, Roberts RL, Burt MJ, et al: Effect of inflammatory bowel disease classification changes on NOD2 genotype-phenotype associations in a population-based cohort. Inflamm Bowel Dis 2007; 13: 1220-1227.
4. Anderson CA, et al: Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 2011; 43: 246-252.
5. Browning BL, et al: Gender-stratified analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian cohorts. J Med Genet 2008; 45: 36-42.
6. Lee JC, et al: Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway. Cell 2013; 155: 57-69.
7. Jostins L, et al: Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491: 119-124.
8. Franke A, et al: Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010; 42: 1118-1125.
9. Huang C, et al: Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans. Gastroenterology 2015; 149: 1575-1586.
10. Gearry RB, et al: CARD15 allele frequency differences in New Zealand Maori: ancestry specific susceptibility to Crohn's disease in New Zealand? Gut 2006; 55: 580.
11. Juyal G, et al: Genome-wide association scan in north Indians reveals three novel HLA-independent risk loci for ulcerative colitis. Gut 2015; 64: 571-579.
12. Yang SK, et al: Genome-wide association study of Crohn's disease in Koreans revealed three new susceptibility loci and common attributes of genetic susceptibility across ethnic populations. Gut 2014; 63: 80-87.
13. Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-1315.
14. Gane EJ, et al: Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C. N Engl J Med 2013; 368: 34-44.
15. Naggie S, et al: Ledipasvir and sofosbuvir for HCV in patients coinfected with HIV-1. N Engl J Med 2015; 373: 705-713.
16. Molodecky NA, et al: Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142: 46-54.e42; quiz e30.
17. Ng SC: Emerging leadership lecture: inflammatory bowel disease in Asia: emergence of a 'Western' disease. J Gastroenterol Hepatol 2015; 30: 440-445.
18. Ooi CJ, et al: The Asia Pacific consensus statements on Crohn's disease part 1: definition, diagnosis and epidemiology. J Gastroenterol Hepatol 2015, Epub ahead of print.
19. Gearry RB, et al: High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study. Inflamm Bowel Dis 2006; 12: 936-943.
20. Gearry RB, Richardson AK, Frampton CM, Dodgshun AJ, Barclay ML: Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol 2010; 25: 325-333.
21. Gent AE, Hellier MD, Grace RH, Swarbrick ET, Coggon D: Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994; 343: 766-767.
22. Gilat T, Hacohen D, Lilos P, Langman MJ: Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study. Scand J Gastroenterol 1987; 22: 1009-1024.
23. Probert CS, Jayanthi V, Pinder D, Wicks AC, Mayberry JF: Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut 1992; 33: 687-693.
24. Probert CS, et al: Crohn's disease in Bangladeshis and Europeans in Britain: an epidemiological comparison in Tower Hamlets. Postgrad Med J 1992; 68: 914-920.
25. Ananthakrishnan AN: Environmental risk factors for inflammatory bowel diseases: A review. Dig Dis Sci 2015; 60: 290-298.
26. Calkins BM: A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989; 34: 1841-1854.
27. Ng SC, et al: Environmental risk factors in inflammatory bowel disease: A populationbased case-control study in Asia-Pacific. Gut 2015; 64: 1063-1071.
28. Reif S, Klein I, Arber N, Gilat T: Lack of association between smoking and inflammatory bowel disease in Jewish patients in Israel. Gastroenterology 1995; 108: 1683-1687.
29. Reif S, et al: Lack of association between smoking and Crohn's disease but the usual association with ulcerative colitis in Jewish patients in Israel: A multicenter study. Am J Gastroenterol 2000; 95: 474-478.
30. Ng SC, et al: Geographical variability and environmental risk factors in inflammatory bowel disease. Gut 2013; 62: 630-649.
31. Watson Ng WS, Hampartzoumian T, Lloyd AR, Grimm MC: A murine model of appendicitis and the impact of inflammation on appendiceal lymphocyte constituents. Clin Exp Immunol 2007; 150: 169-178.
32. Ko Y, et al: Inflammatory bowel disease environmental risk factors: A population-based case-control study of Middle Eastern migration to Australia. Clin Gastroenterol Hepatol 2015; 13: 1453-1463.e1.
33. Sakamoto N, et al: Dietary risk factors for inflammatory bowel disease: A multicenter casecontrol study in Japan. Inflamm Bowel Dis 2005; 11: 154-163.
34. Costea I, et al: Interactions between the dietary polyunsaturated fatty acid ratio and genetic factors determine susceptibility to pediatric Crohn's disease. Gastroenterology 2014; 146: 929-931.
35. Ng SC, et al: Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology 2013; 145: 158-165.e2.
36. Ungaro R, et al: Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis: A meta-analysis. Am J Gastroenterol 2014; 109: 1728-1738.
37. Roberts RL, et al: Evidence of interaction of CARD8 rs2043211 with NALP3 rs35829419 in Crohn's disease. Genes Immun 2010; 11: 351-356.
38. Glubb DM, et al: NOD2 and ATG16L1 polymorphisms affect monocyte responses in Crohn's disease. World J Gastroenterol 2011; 17: 2829-2837.
39. Doecke JD, et al: Smoking behaviour modifies IL23r-associated disease risk in patients with Crohn's disease. J Gastroenterol Hepatol 2015; 30: 299-307.
40. Ponder A, Long MD: A clinical review of recent findings in the epidemiology of inflammatory bowel disease. Clin Epidemiol 2013; 5: 237-247.